Hologic Inc
NASDAQ:HOLX
Hologic Inc
NASDAQ:HOLX
Price:
75.14 USD
-0.81%
Market Closed
Updated:
May 13, 2024
Hologic Inc
Income from Continuing Operations
|
Hologic Inc
Income from Continuing Operations Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Hologic Inc
NASDAQ:HOLX
|
Income from Continuing Operations
$466.5m
|
CAGR 3-Years
-37%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Income from Continuing Operations
$1.3B
|
CAGR 3-Years
7%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
3%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Income from Continuing Operations
$1.8B
|
CAGR 3-Years
92%
|
CAGR 5-Years
0%
|
CAGR 10-Years
17%
|
|
|
Stryker Corp
NYSE:SYK
|
Income from Continuing Operations
$3.4B
|
CAGR 3-Years
34%
|
CAGR 5-Years
11%
|
CAGR 10-Years
16%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Income from Continuing Operations
$5.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
16%
|
CAGR 10-Years
13%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Income from Continuing Operations
$2B
|
CAGR 3-Years
19%
|
CAGR 5-Years
12%
|
CAGR 10-Years
14%
|
See Also
What is Hologic Inc's Income from Continuing Operations?
Income from Continuing Operations
466.5m
USD
466.5m
USD
Based on the financial report for Mar 30, 2024, Hologic Inc's Income from Continuing Operations amounts to 466.5m USD.
What is Hologic Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 3Y
-37%
-37%
Over the last year, the Income from Continuing Operations growth was -38%. The average annual Income from Continuing Operations growth rates for Hologic Inc have been -37% over the past three years .
You don't have any saved screeners yet
